Sandu Pharmaceuticals standalone net profit declines 87.88% in the March 2026 quarter

Sales rise 19.76% to Rs 16.85 crore

Net profit of Sandu Pharmaceuticals declined 87.88% to Rs 0.04 crore in the quarter ended March 2026 as against Rs 0.33 crore during the previous quarter ended March 2025. Sales rose 19.76% to Rs 16.85 crore in the quarter ended March 2026 as against Rs 14.07 crore during the previous quarter ended March 2025.

For the full year,net profit rose 14.19% to Rs 1.77 crore in the year ended March 2026 as against Rs 1.55 crore during the previous year ended March 2025. Sales rose 4.08% to Rs 69.93 crore in the year ended March 2026 as against Rs 67.19 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	16.85	14.07	20	69.93	67.19	4
OPM %	3.32	3.20	-	4.30	4.11	-
PBDT	0.90	0.49	84	3.34	2.83	18
PBT	0.74	0.34	118	2.66	2.16	23
NP	0.04	0.33	-88	1.77	1.55	14

Powered by Capital Market - Live News